|50.56||+0.14 / +0.28%|
Data as of 4:00pm ET
|50.56||0.00 / 0.00%|
The 18 analysts offering 12-month price forecasts for Bristol-Myers Squibb Co have a median target of 56.00, with a high estimate of 63.00 and a low estimate of 34.00. The median estimate represents a +10.76% increase from the last price of 50.56.
The current consensus among 23 polled investment analysts is to Buy stock in Bristol-Myers Squibb Co. This rating has held steady since October, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.